The upgrade is based on Moody's expectation of robust earnings growth for Eli Lilly in the coming years. This growth is anticipated to be driven by the company's incretin portfolio, which includes ...

BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

About Events Features Stroke at 41 leads Indy man to give back New procedure offers hope for atrial fibrillation patients Weight loss and beyond Cardiac Arrest vs. Heart Attack What you should know ...

The best in the biggest game The Super Bowl MVP through the years has ranged from supertars to occasional unknowns. There have been some greats like Joe Montana and To9m Brady who have won multiple ...